共 100 条
- [1] Witlin AG(1998)Magnesium sulfate therapy in preeclampsia and eclampsia Obstet Gynecol 92 883-889
- [2] Sibai BM(2004)Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome Clin Perinatol 31 807-833
- [3] Barton JR(2004)Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count Obstet Gynecol 103 981-991
- [4] Sibai BM(1998)Etiology and pathogenesis of preeclampsia: current concepts Am J Obstet Gynecol 179 1359-1375
- [5] Sibai BM(1997)Human cytotrophoblast differentiation/invasion is abnormal in preeclampsia Am J Pathol 151 1809-1818
- [6] Dekker GA(1998)HELLP! A cry for laboratory assistance: a comprehensive review of the HELLP syndrome highlighting the role of the laboratory Hematopathol Mol Hematol 11 147-171
- [7] Sibai BM(2004)Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction Hypertens Pregnancy 23 171-189
- [8] Lim KH(1997)Activin A and inhibin A as possible endocrine markers for pre-eclampsia Lancet 349 1285-1288
- [9] Zhou Y(2005)Quad screen as a predictor of adverse pregnancy outcome Obstet Gynecol 106 260-267
- [10] Janatpour M(2005)Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry Int J Gynaecol Obstet 89 251-257